Triglyceride breakdown from lipid droplets regulates the inflammatory response in macrophages

In response to inflammatory activation by pathogens, macrophages accumulate triglycerides in intracellular lipid droplets. The mechanisms underlying triglyceride accumulation and its exact role in the inflammatory response of macrophages are not fully understood. Here, we aim to further elucidate th...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 119; no. 12; p. e2114739119
Main Authors van Dierendonck, Xanthe A M H, Vrieling, Frank, Smeehuijzen, Lisa, Deng, Lei, Boogaard, Joline P, Croes, Cresci-Anne, Temmerman, Lieve, Wetzels, Suzan, Biessen, Erik, Kersten, Sander, Stienstra, Rinke
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 22.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In response to inflammatory activation by pathogens, macrophages accumulate triglycerides in intracellular lipid droplets. The mechanisms underlying triglyceride accumulation and its exact role in the inflammatory response of macrophages are not fully understood. Here, we aim to further elucidate the mechanism and function of triglyceride accumulation in the inflammatory response of activated macrophages. Lipopolysaccharide (LPS)-mediated activation markedly increased triglyceride accumulation in macrophages. This increase could be attributed to up-regulation of the hypoxia-inducible lipid droplet–associated (HILPDA) protein, which down-regulated adipose triglyceride lipase (ATGL) protein levels, in turn leading to decreased ATGL-mediated triglyceride hydrolysis. The reduction in ATGL-mediated lipolysis attenuated the inflammatory response in macrophages after ex vivo and in vitro activation, and was accompanied by decreased production of prostaglandin-E2 (PGE2) and interleukin-6 (IL-6). Overall, we provide evidence that LPS-mediated activation of macrophages suppresses lipolysis via induction of HILPDA, thereby reducing the availability of proinflammatory lipid precursors and suppressing the production of PGE2 and IL-6.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Katherine Fitzgerald, University of Massachusetts Medical School, Worcester, MA; received August 13, 2021; accepted January 26, 2022
Author contributions: X.A.M.H.v.D., S.K., and R.S. designed research; X.A.M.H.v.D., F.V., L.S., L.D., J.P.B., and C.-A.C. performed research; L.T., S.W., and E.B. contributed new reagents/analytic tools; X.A.M.H.v.D. and F.V. analyzed data; and X.A.M.H.v.D., S.K., and R.S. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2114739119